These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 8610107)
1. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain. Hoshi M; Takashima A; Noguchi K; Murayama M; Sato M; Kondo S; Saitoh Y; Ishiguro K; Hoshino T; Imahori K Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2719-23. PubMed ID: 8610107 [TBL] [Abstract][Full Text] [Related]
2. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. Imahori K; Uchida T J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387 [TBL] [Abstract][Full Text] [Related]
3. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons. Takahashi M; Yasutake K; Tomizawa K J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067 [TBL] [Abstract][Full Text] [Related]
4. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590 [TBL] [Abstract][Full Text] [Related]
5. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Takahashi M; Tomizawa K; Ishiguro K Brain Res; 2000 Feb; 857(1-2):193-206. PubMed ID: 10700568 [TBL] [Abstract][Full Text] [Related]
6. Different localization of tau protein kinase I/glycogen synthase kinase-3 beta from glycogen synthase kinase-3 alpha in cerebellum mitochondria. Hoshi M; Sato M; Kondo S; Takashima A; Noguchi K; Takahashi M; Ishiguro K; Imahori K J Biochem; 1995 Oct; 118(4):683-5. PubMed ID: 8576078 [TBL] [Abstract][Full Text] [Related]
7. Possible role of tau protein kinases in pathogenesis of Alzheimer's disease. Imahori K; Hoshi M; Ishiguro K; Sato K; Takahashi M; Shiurba R; Yamaguchi H; Takashima A; Uchida T Neurobiol Aging; 1998; 19(1 Suppl):S93-8. PubMed ID: 9562476 [TBL] [Abstract][Full Text] [Related]
8. Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. Takahashi M; Tomizawa K; Kato R; Sato K; Uchida T; Fujita SC; Imahori K J Neurochem; 1994 Jul; 63(1):245-55. PubMed ID: 7515946 [TBL] [Abstract][Full Text] [Related]
9. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation. Elyaman W; Terro F; Wong NS; Hugon J Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446 [TBL] [Abstract][Full Text] [Related]
10. Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassembly. Elyaman W; Yardin C; Hugon J J Neurochem; 2002 May; 81(4):870-80. PubMed ID: 12065646 [TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Li M; Wang X; Meintzer MK; Laessig T; Birnbaum MJ; Heidenreich KA Mol Cell Biol; 2000 Dec; 20(24):9356-63. PubMed ID: 11094086 [TBL] [Abstract][Full Text] [Related]
13. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain. Song JS; Yang SD J Protein Chem; 1995 Feb; 14(2):95-105. PubMed ID: 7786411 [TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. Lau KF; Miller CC; Anderton BH; Shaw PC Genomics; 1999 Sep; 60(2):121-8. PubMed ID: 10486203 [TBL] [Abstract][Full Text] [Related]
15. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173 [TBL] [Abstract][Full Text] [Related]
16. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo. Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423 [TBL] [Abstract][Full Text] [Related]
17. [Involvement of tau protein kinase in amyloid-beta-induced neurodegeneration]. Ishiguro K Rinsho Byori; 1998 Oct; 46(10):1003-7. PubMed ID: 9816911 [TBL] [Abstract][Full Text] [Related]
18. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β. Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324 [TBL] [Abstract][Full Text] [Related]
19. Involvement of tau protein kinase I in paired helical filament-like phosphorylation of the juvenile tau in rat brain. Takahashi M; Tomizawa K; Ishiguro K; Takamatsu M; Fujita SC; Imahori K J Neurochem; 1995 Apr; 64(4):1759-68. PubMed ID: 7891105 [TBL] [Abstract][Full Text] [Related]
20. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons. Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]